News
Omaxe rewards its business associates with Europe tour
Rewarding them for their performance, real estate company Omaxe took a group of 100 business associates, their family members and employees on a leisure tour to Europe.
According to a press release, the seven-day, three-city tour of Amsterdam, Brussels and Zurich culminated in a gala dinner and Star Performers Meet. On behalf of Omaxe CMD Rohtas Goel and CEO Mohit Goel, UP Business Head Shikha Garggave away the awards to top performers for record sales achieved in 2014-15.
Commenting on the development, Omaxe CMD Rohtas Goel said, “We are very proud of what our associates have achieved. The record sales number achieved in 2014-15 is a result of their hard work and dedication while upholding the business philosophy of the company. We are committed to protecting their interest and well-being, and as a result such tours are undertaken to help them stay motivated even while keeping them abreast with company’s future goals.”
Omaxe CEO Mohit Goel said, “Business Associates are an inherent part of our work philosophy and it beckons upon us to ensure they work in the right environment with adequate motivation that helps them drive business for the company. Even in difficult market conditions, our new offerings have found enthusiastic takers and the credit goes to our associates’ superlative effort.”
-
News4 weeks ago
KW Delhi 6 Mall Onboards New Brands
-
News4 weeks ago
Commercial Realty Gets Tech Savvy: Fast Construction, Enhanced Convenience
-
News3 weeks ago
Godrej Properties Sells Rs 3k cr+ Homes of Godrej Zenith, Gurugram, within 3 days
-
News3 weeks ago
RBI’s Status Quo on Key Policy Rates to Help Maintain the Real Estate Growth Momentum, Say Industry Stalwarts
-
News2 weeks ago
Olive Announces Dhruv Kalro as Co-Founder
-
News1 week ago
Noida’s High-Rise Societies Face Multiple Challenges Despite Rapid Urban Growth
-
News3 weeks ago
Godrej Properties Sells 5000+ Homes of Rs 9.5 cr in Q4FY24, Bookings up 84% YoY
-
News2 weeks ago
Vestian: Domestic Investors Dominate Institutional Investments in Jan-Mar’24